Screening compound: InChI=1S/C14H14N2O2S/c17-14(16-5-7-18-8-6-16)11-3-4-12(15-10-11)13-2-1-9-19-13/h1-4,9-10H,5-8H2

Screening compound: InChI=1S/C14H14N2O2S/c17-14(16-5-7-18-8-6-16)11-3-4-12(15-10-11)13-2-1-9-19-13/h1-4,9-10H,5-8H2
Screening compound: InChI=1S/C14H14N2O2S/c17-14(16-5-7-18-8-6-16)11-3-4-12(15-10-11)13-2-1-9-19-13/h1-4,9-10H,5-8H2 alternative view

Chemical Structure Depiction of ChemDiv screening compound
InChI=1S/C14H14N2O2S/c17-14(16-5-7-18-8-6-16)11-3-4-12(15-10-11)13-2-1-9-19-13/h1-4,9-10H,5-8H2

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M710-1109

Molecular Formula

C14H14N2O2S (C14 H14 N2 O2 S)

Compound Name

4-[6-(thiophen-2-yl)pyridine-3-carbonyl]morpholine

IUPAC name

4-[6-(thiophen-2-yl)pyridine-3-carbonyl]morpholine

SMILES

O=C(c(cc1)cnc1-c1cccs1)N1CCOCC1

InChI

InChI=1S/C14H14N2O2S/c17-14(16-5-7-18-8-6-16)11-3-4-12(15-10-11)13-2-1-9-19-13/h1-4,9-10H,5-8H2

InChI Key

LUXLVSLTPXYIJA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27551873

InChI=1S/C14H14N2O2S/c17-14(16-5-7-18-8-6-16)11-3-4-12(15-10-11)13-2-1-9-19-13/h1-4,9-10H,5-8H2 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Cardiovascular Library (22201 compounds)

Fragments Library (11262 compounds)

GABA Library (7115 compounds)

SmartTM Library (51161 compounds)

Soluble Diversity Library (15920 compounds)

Epitranscriptome Focused Small Molecule Library (20952 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cardiovascular
  • Eye
  • Nervous system
  • Hemic and lymphatic
  • Congenital
  • Metabolic
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Structure:
  • Fragments
Targets:
  • GPCR
  • Ion Channels
  • Phosphatases
Mechanism of action:
  • Receptor's ligands
  • Epigenetic

References: we are preparing a list of scientific research reports with InChI=1S/C14H14N2O2S/c17-14(16-5-7-18-8-6-16)11-3-4-12(15-10-11)13-2-1-9-19-13/h1-4,9-10H,5-8H2 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound InChI=1S/C14H14N2O2S/c17-14(16-5-7-18-8-6-16)11-3-4-12(15-10-11)13-2-1-9-19-13/h1-4,9-10H,5-8H2?
Check Price and Availability of InChI=1S/C14H14N2O2S/c17-14(16-5-7-18-8-6-16)11-3-4-12(15-10-11)13-2-1-9-19-13/h1-4,9-10H,5-8H2, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of InChI=1S/C14H14N2O2S/c17-14(16-5-7-18-8-6-16)11-3-4-12(15-10-11)13-2-1-9-19-13/h1-4,9-10H,5-8H2 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for InChI=1S/C14H14N2O2S/c17-14(16-5-7-18-8-6-16)11-3-4-12(15-10-11)13-2-1-9-19-13/h1-4,9-10H,5-8H2
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for InChI=1S/C14H14N2O2S/c17-14(16-5-7-18-8-6-16)11-3-4-12(15-10-11)13-2-1-9-19-13/h1-4,9-10H,5-8H2
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of InChI=1S/C14H14N2O2S/c17-14(16-5-7-18-8-6-16)11-3-4-12(15-10-11)13-2-1-9-19-13/h1-4,9-10H,5-8H2 available by request